Critical Care

official impact factor 4.60

This article is part of the supplement: Severe sepsis and drotrecogin alfa (activated)

The protein C pathway: implications for the design of the RESPOND study

Burkhard Vangerow*, Andrew F Shorr, Duncan Wyncoll, Jonathan Janes, David R Nelson and Konrad Reinhart

Critical Care 2007, 11(Suppl 5):S4 doi:10.1186/cc6155

Accesses  

  • Last 30 days: 42 accesses
  • Last 365 days: 490 accesses
  • All time: 4100 accesses